Dr Kyle is Chairman of the Scientific Advisory Board of the International Myeloma Foundation (IMF) and serves on the Board of Directors of the IMF; he is Chairman of the Scientific Advisory Committee of the International Waldenström’s Macroglobulinemia Foundation (IWMF). He is a Master, American College of Physicians, and an honorary member of the Royal Society of Pathologists, London. He served as the first President of the International Society of Amyloidosis as well as the International Myeloma Society.

He was Chairman of the Myeloma Committee of the Eastern Cooperative Oncology Group for 12 years and for 6 years served as Secretary-General of the International Society of Hematology. Dr Kyle lectures widely and has contributed more than 1050 articles and book chapters as well as over 1350 abstracts to the literature. Dr Kyle was the first recipient of the Robert A. Kyle Lifetime Achievement Award from the International Myeloma Foundation and the Robert A. Kyle Award from the IWMF as well as the Robert A. Kyle Award for Outstanding Clinician Scientist from Mayo Clinic, and has received the Mayo Clinic’s Henry S. Plummer Distinguished Internist Award, Distinguished Clinician Award, and Distinguished Alumni Award. He is one of two recipients of both the David A. Karnofsky Award and Lecture from the American Society of Clinical Oncology in 2007 and the Wallace Coulter Award from the American Society of Hematology in 2008 which are their highest awards. He received the 2013 Northwestern University Feinberg School of Medicine Distinguished Alumnus Award and the John Phillips Award from the American College of Physicians in 2015.